Home / India News / Panacea Biotec receives order worth USD 24.32 mn for Pentavalent Vaccine

Panacea Biotec receives order worth USD 24.32 mn for Pentavalent Vaccine

Last Updated : Dec 19 2019 | 11:31 AM IST

From UNICEF and PAHO

Panacea Biotec has received awards worth USD 24.32 million (over Rs 170 crore) from U.N. Agencies (UNICEF and PAHO) for supply of its Easyfive-TT, a fully liquid WHO prequalified wP based Pentavalent Vaccine (DTwPHepB- Hib).

UNICEF award is for calendar year 2020 and award of PAHO is for three (3) calendar years i.e. 2020-2022.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

Trident secures patent for 'Terry fabric weave and resulting terry fabric'

NMDC update on modified mining plan of Kumaraswamy mines

Gujarat State Petronet appoints MD

L&T Financial Holdings to raise up to Rs 300 cr by way of private placement of CRPS

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 19 2019 | 11:07 AM IST